Stifel Financial’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Stifel Financial's EW Position: Q2 2026 in Review
Stifel Financial increased its Edwards Lifesciences (EW) stake by 16% in Q2 2026, buying an estimated $2.49M and bringing the position to 212,736 shares worth $19.2M. The position accounts for 0.02% of the portfolio, ranked #700.
Stifel Financial first reported a position in EW in Q1 2014 and has held it in 50 quarters since. The position peaked at $52.4M in Q1 2022. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Stifel Financial held 212,736 shares of Edwards Lifesciences worth $19.2M as of Q2 2026.
- Stifel Financial bought 29,709 Edwards Lifesciences shares in Q2 2026, an estimated $2.49M.
- Edwards Lifesciences made up 0.02% of Stifel Financial's portfolio in Q2 2026, its #700 holding.
- Stifel Financial first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 50 quarters since.
- Stifel Financial's Edwards Lifesciences position peaked at $52.4M in Q1 2022.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.